HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (81) Citing Articles via Google Scholar Google Scholar Articles by Kjerulff, K H Articles by Langenberg, P W Search for Related Content PubMed PubMed Citation Articles by Kjerulff, K H Articles by Langenberg, P W

Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992.

K H Kjerulff, B A Erickson and P W Langenberg

Department of Epidemiology and Preventive Medicine, School of Medicine, University of Maryland, Baltimore 21201, USA.

OBJECTIVES. This study sought to describe prevalence rates of chronic gynecological conditions and correlates of these conditions in a representative sample of US women. METHODS. National Health Interview Survey data from 1984 through 1992 for women aged 18 to 50 were used. RESULTS. The estimated annual prevalence rate for the reported presence of one or more gynecological conditions was 97.1 per 1,000 women. Menstrual disorders were most common, with an annual prevalence rate of 53.0 per 1,000 women. Adnexal conditions and fibroids were the next most common conditions, with rates per 1,000 women of 16.6 and 9.2, respectively. Prolapse, endometriosis, and fibroids were the conditions most likely to lead to hysterectomy within the year prior to the interview. More than three quarters (77.1%) of women with gynecological conditions had talked with a doctor in the previous year concerning their condition, and 28.8% reported spending 1 or more days in bed in the previous year because of their condition. CONCLUSIONS. Nearly a tenth of American women aged 18 to 50 report having one or more chronic gynecological conditions annually, the most common being disorders of menstruation.

This article has been cited by other articles:

				S.-W. Guo, P. Simsa, C. M. Kyama, A. Mihalyi, V. Fulop, E.-E. R. Othman, and T. M. D'Hooghe Reassessing the evidence for the link between dioxin and endometriosis: from molecular biology to clinical epidemiology Mol. Hum. Reprod., October 1, 2009; 15(10): 609 - 624. [Abstract] [Full Text] [PDF]

				S. A Missmer Commentary: Endometriosis--epidemiologic considerations for a potentially 'high-risk' population Int. J. Epidemiol., August 1, 2009; 38(4): 1154 - 1155. [Full Text] [PDF]

				J.L. Brun, C. Galant, D. Delvaux, P. Lemoine, P. Henriet, P.J. Courtoy, and E. Marbaix Menstrual activity of matrix metalloproteinases is decreased in endometrium regenerating after thermal ablation Hum. Reprod., February 1, 2009; 24(2): 333 - 340. [Abstract] [Full Text] [PDF]

				G. Hudelist, A. Huber, M. Knoefler, S. Haider, A. Kolbus, K. Czerwenka, S. Helmy, E. Kubista, and C. F. Singer {beta}-HCG/LH Receptor ({beta}-HCG/LH-R) Expression in Eutopic Endometrium and Endometriotic Implants: Evidence for {beta}-HCG Sensitivity of Endometriosis Reproductive Sciences, July 1, 2008; 15(6): 543 - 551. [Abstract] [PDF]

				H. Utsunomiya, Y.-H. Cheng, Z. Lin, S. Reierstad, P. Yin, E. Attar, Q. Xue, G. Imir, S. Thung, E. Trukhacheva, et al. Upstream Stimulatory Factor-2 Regulates Steroidogenic Factor-1 Expression in Endometriosis Mol. Endocrinol., April 1, 2008; 22(4): 904 - 914. [Abstract] [Full Text] [PDF]

				G. Hudelist, K. Czerwenka, J. Keckstein, C. Haas, A. Fink-Retter, D. Gschwantler-Kaulich, E. Kubista, and C.F. Singer Expression of Aromatase and Estrogen Sulfotransferase in Eutopic and Ectopic Endometrium: Evidence for Unbalanced Estradiol Production in Endometriosis Reproductive Sciences, December 1, 2007; 14(8): 798 - 805. [Abstract] [PDF]

				H. Dassen, C. Punyadeera, R. Kamps, B. Delvoux, A. Van Langendonckt, J. Donnez, B. Husen, H. Thole, G. Dunselman, and P. Groothuis Estrogen metabolizing enzymes in endometrium and endometriosis Hum. Reprod., December 1, 2007; 22(12): 3148 - 3158. [Abstract] [Full Text] [PDF]

				G.M. Buck Louis, J.M. Weiner, B.W. Whitcomb, R. Sperrazza, E.F. Schisterman, D.T. Lobdell, K. Crickard, H. Greizerstein, and P.J. Kostyniak Environmental PCB exposure and risk of endometriosis Hum. Reprod., January 1, 2005; 20(1): 279 - 285. [Abstract] [Full Text] [PDF]

				M. T. Beinfeld, J. L. Bosch, K. B. Isaacson, and G. S. Gazelle Cost-Effectiveness of Uterine Artery Embolization and Hysterectomy for Uterine Fibroids Radiology, January 1, 2004; 230(1): 207 - 213. [Abstract] [Full Text] [PDF]

				P. K. Dhillon and V. L. Holt Recreational Physical Activity and Endometrioma Risk Am. J. Epidemiol., July 15, 2003; 158(2): 156 - 164. [Abstract] [Full Text] [PDF]

				B. Gurates, S. Sebastian, S. Yang, J. Zhou, M. Tamura, Z. Fang, T. Suzuki, H. Sasano, and S. E. Bulun WT1 and DAX-1 Inhibit Aromatase P450 Expression in Human Endometrial and Endometriotic Stromal Cells J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4369 - 4377. [Abstract] [Full Text] [PDF]

				Menstruation: New Attitudes and Choices Journal Watch Women's Health, October 31, 2001; 2001(1031): 9 - 9. [Full Text]

				E. Weir The public health toll of endometriosis Can. Med. Assoc. J., April 1, 2001; 164(8): 1201 - 1201. [Full Text] [PDF]

				10% of Women under 50 Report Chronic Gynecologic Problems Journal Watch Women's Health, April 1, 1996; 1996(401): 6 - 6. [Full Text]